Inside America’s Horrifying Modern-Day Eugenics Movement
By Cassie Da Costa,
The Daily Beast
| 05. 18. 2020
The new documentary Belly of the Beast explores the epidemic of forced sterilizations within the female prison population of California.
Director Erika Cohn’s new film, Belly of the Beast, part of the Human Rights Watch Film Festival which goes digital in the U.S. from June 11 to 20, brings to the fore the undeniable and continued legacy of eugenics and forced sterilization in the state of California.
The documentary follows the case of Kelli Dillon, a black mother who was told she had cysts and needed surgery while incarcerated, only to discover, over a year later and after months of menopausal symptoms and extreme weight loss at the age of 24, that she had been given a hysterectomy (Dillon’s doctors never told her they had performed a hysterectomy on her). Risking retaliation, Dillon decided to speak out even while she was still in jail and teamed up with the prison abolition legal aid organization Justice Now, founded by attorney Cynthia Chandler, to find justice. Belly of the Beast is about the freedom work Dillon, Chandler, and the Justice Now team—whose board members are all currently incarcerated women—do against all odds in the service of female survivors of...
Related Articles
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris, BioNews | 04.20.2026
By George Janes, BioNews | 04.20.2026
New regulations in sperm donation are being implemented by Belgium's Federal Agency for Medicines and Health Products (FAMHP), following revelations regarding the use of sperm carrying a cancer-causing mutation, and widespread breaches of donor limits.
In 2025, it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...